Research

NUWA

We present NUWA, a computational pipeline for robust inference of protein abundances missing in mass spectrometry proteomic profiles. …

Pharmacogenomic profiling of intra-tumor heterogeneity of liver cancer organoids

Inter- and intra-tumor heterogeneity is a major hurdle in primary liver cancer (PLC) precision therapy. In collaboration with Prof. …

Dual roles of Beta-arrestin 1 in mediating cell metabolism and proliferation

β-Arrestin 1 (ARRB1) has been known as a key negative regulator of G protein-coupled receptor signaling. During the past decade, it has …

ReProMSig

We provide the Reproducible Prognosis Molecular Signature platform (ReProMSig), to facilitate biomarker development and applications in …

Quantitative comparison of Matrigel dissolving methods

By integrative analysis of label-free proteomes of Matrigel and SILAC proteomes of organoids collected by three methods respectively, …

Proteogenomic Analysis of Gastric Cancer (GC)

Combining whole exome sequencing, RNA-sequencing, and mass spectrometry-based proteomic profiling to elucidate GC molecular landscape.

GPGC

ICGC-ARGO Project: Genomic and Proteomic Characterisation of Gastric Cancer.

PINA 3.0

An integrated platform for protein interaction network construction, filtering, analysis, visualization and cancer-context annotation.

CVCDAP

A powerful Cancer Virtual Cohort Discovery Analysis Platform with large cancer datasets integrated.

Members

Director

Avatar

Jianmin Wu

Director,
Center for Cancer Bioinformatics

Member,
ICGC-ARGO Scientific Planning Committee

Staff

Avatar

Lihua Cao

Research Staff

Avatar

Yang Du

Research Staff

Avatar

Man Wang

Research Staff

Avatar

Jiale Chen

Research Staff

Grad Students

Avatar

Zirui Li

PhD student (2024-)

Avatar

Xinya Peng

Master student (2023-)

Alumni

Avatar

Yuhao Xie

Master student (2018-2021) , co-supervised with Dr. Ence Yang

Avatar

Yanru Hai

Master student (2019-2022)

Avatar

Huan Yu

Ph.D (2018-2022)

Avatar

Ting Zhang

Research assistant

Avatar

Tingting Zhao

Ph.D (2019-2022)

Avatar

Meng Cai

Master Student(2018 - 2021), co-supervised with Dr. Ence Yang

Avatar

Xiaoqing Guan

Ph.D (2017-2020), co-supervised with Prof. Jiafu Ji

Avatar

Yu Cai

Master student (2017-2020)

Avatar

Sijia Cui

Research Staff

Avatar

Chenyu Guo

Research Staff

Avatar

Yixuan Shu

Master student (2021-2024)

Avatar

Yang Yang

Research Staff

Recent News

Our recent work analyzing multi-region organoids reveal inter- and intra-tumor pharmacogenomic heterogeneity in primary liver cancer, in collaberation with Prof. Zhang Ning. Please read the article published in Cancer Cell for more details.

ReProMSig (Reproducible Prognosis Molecular Signature) has been online at Briefings in Bioinformatics. Congratulations to Tingting Zhao and Lihua Cao!

We are excited to be a part of a Lancet Oncology Commission focusing on cancer genomics and precision oncology. This new commission will be coordinated by the International Cancer Genome Consortium Accelerating Research in Genomic Oncology (ICGC-ARGO) initiative, and bring together international experts with relevant expertise across a range of fields, to offer practical solutions for key challenges in ensuring sustainable and equitable access to omics testing and a blueprint for advancing cancer diagnosis and treatment.

Join Us

Open positions for research faculty and students

Open positions

Contact

  • +86-10-88196986
  • Peking University Cancer Hospital & Institute, 52 Fu-Cheng Road, Hai-Dian District, Beijing 100142, China
    北京市海淀区阜成路52号,北京大学肿瘤医院 西门科研楼608-2室